Off-Label Use of an Anti-Hypertensive to Treat Epilepsy
University of Arizona researchers have found the angiotensin II receptor blocker, Candesartan, to effectively reduce epileptic activity.
Background:
As the most prevalent neurological disease, epilepsy is estimated to affect around 50 million people worldwide. In the United States, it is estimated that around 470,000 children and 3 million adults...
Published: 11/14/2024
|
Inventor(s): Michael Hammer, Erfan Bahramnejad
Keywords(s):
Category(s): Technology Classifications > Healthcare Portfolios > Neurology, Technology Classifications > Life Sciences > Therapeutics
|